Distinct pathoclinical clusters among patients with uncontrolled type 2 diabetes: results from a prospective study in rural India
Open Access
- 10 February 2022
- journal article
- research article
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 10 (1) , e002654
Abstract
Introduction Inadequate glycemic control among patients with type 2 diabetes mellitus (T2DM) poses an enormous challenge. Whether this uncontrolled T2DM population is a heterogenous mix of disease subtypes remains unknown. Identification of these subtypes would result in a customized T2DM management protocol thereby paving the way toward personalized therapy. Research design and methods Electronic health records of 339 patients with uncontrolled T2DM patients followed up for a median period of 14 months were analyzed using Uniform Manifold Approximation and Projection followed by density-based spatial clustering of applications with noise. Baseline clinical features and final diagnoses with drug combinations were selected in the analysis. A 30 min oral glucose tolerance test was next performed for assessing the underlying insulin resistance and β cell dysfunction. Results Three major clusters were identified. The first cluster characterized by recent onset T2DM had moderately preserved β cell function. The second cluster with a longer duration of T2DM and associated hypertension showed the best glycemic control with dual antidiabetic therapy. The third cluster with the longest history of T2DM and no history of hypertension had the worst glycemic control in spite of the highest percentage of patients on triple therapy (34.58%) and quadruple therapy (8.41%). Conclusions Uncontrolled T2DM comprises a heterogeneous population with respect to disease duration, presence of co-morbidities and β cell function without significant difference in insulin resistance. Stratifying them on the basis of pathoclinical features is the first step toward a personalized management in T2DM.Keywords
Funding Information
- ICMR (3/1/3/JRF-2017/HRD-LS/56429/54)
- Indian Council of Medical Research (5/4/5-6/Diab./2021-NCD-III)
- MHRD (IMP/2018/000471)
This publication has 32 references indexed in Scilit:
- Insulin‐secretion capacity in normal glucose tolerance, impaired glucose tolerance, and diabetes in obese and non‐obese Japanese patientsJournal of Diabetes Investigation, 2011
- Reduced Time Points to Calculate the Composite IndexDiabetes Care, 2010
- Individualizing Therapies in Type 2 Diabetes Mellitus Based on Patient Characteristics: What We Know and What We Need to KnowThe Journal of Clinical Endocrinology & Metabolism, 2010
- Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6,671 adults with diabetes in BrazilActa Diabetologica, 2009
- Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose LevelsDiabetes Care, 2009
- Insulin Sensitivity and Insulin Secretion Determined by Homeostasis Model Assessment and Risk of Diabetes in a Multiethnic Cohort of WomenDiabetes Care, 2007
- Obesity and Diabetes in the Developing World — A Growing ChallengeNew England Journal of Medicine, 2007
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- How Useful Is Body Mass Index for Comparison of Body Fatness across Age, Sex, and Ethnic Groups?American Journal of Epidemiology, 1996
- Mechanisms of Insulin Resistance in AgingJournal of Clinical Investigation, 1983